Ectopic neurohypophysis is frequently associated with anterior pituitary hormone deficiencies. Isolated growth hormone deficiency (GHD) or multiple pituitary hormone deficiency (MPHD), in which GHD is associated with one or more other anterior pituitary hormone deficiencies, may develop in these cases. Although the etiology is unclear, traumatic birth, breech delivery and genetic factors have all been considered as possible factors (1,2). Some of the genetic factors include LHX4, HESX1, GLI2, GH-1, GH releasing hormone (GHRH) receptor, POU1F1, PROP-1and SOX3 mutations and have been shown to be important in the development of the pituitary gland. However, studies have failed to implicate a genetic factor in 95% of cases of ectopic neurohypophysis associated with GHD (1,2,3,4,5). In the present study, nonsyndromic cases with ectopic neurohypophysis were evaluated with respect to renal developmental anomalies, while the etiology of GHD was being investigated.
MATERIALS AND METHODS
PatientsTwo-hundred and thirteen cases followed between January 1990 and December 2007 at the Pediatric Endocrinology Department of Ege University Faculty of Medicine with the diagnosis of GHD were included in this study. The medical records of the patients were retrospectively evaluated. Of the total group, 20 (9.3%) cases (7 girls and 13 boys), in whom ectopic neurohypophysis was detected via magnetic resonance imaging (MRI), were included in this study. We analyzed the data regarding chronologic age at the time of diagnosis, standard deviation scores (SDSs) for height and body mass index (BMI) at the time of diagnosis, history of parental consanguinity, difficult birth history, family history of short stature, presence of other pituitary hormone deficiencies or additional anomalies other than ectopic neurohypophysis and presence of renal anomalies. Sagittal and coronal 3-mm-thick slices of the pituitary area were obtained via MRI. All MRI scans were assessed by pediatric neuroradiologists who were not blinded to the clinical information.Two standard GH stimulation tests were performed with insulin and levodopa (L-DOPA). In one neonate, plasma GH levels were measured during spontaneous hypoglycemia. A peak value of less than 10 ng/mL in two tests was regarded as confirmatory for the diagnosis of GHD. Adrenocorticotropic hormone (ACTH) deficiency was diagnosed based on a cortisol level of less than 5 μg/dL and a peak cortisol level of less than 25 μg/dL on ACTH test. The diagnosis of thyroid-stimulating hormone (TSH) deficiency was based on a free thyroxine (fT4) level of less than 0.8 ng/dL in combination with a normal TSH level. Moreover, patients with TSH levels below the normal range were also diagnosed as having TSH deficiency. Thyrotropin-releasing hormone (TRH) stimulation test (7 μg/kg) was also used in the diagnosis of TSH deficiency. Hypogonadotropic hypogonadism was suspected when both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) responses to LH-releasing hormone (LHRH) stimulation test (100 μg/m2) were flat in pubertal patients. Basal and stimulated levels of cortisol, ACTH, TSH, prolactin (PRL), FSH, and LH were measured at sequential time points (15, 30, 60 and 90 minute after stimulation). Each hormone was measured by immunochemiluminescent assay and radioluminescence. Renal anomalies were examined by experienced radiologists via ultrasonography (US). In case of pathological findings on US, the presence of renal anomalies was confirmed via renal scintigraphy and intravenous pyelography (IVP).This study was conducted according to the principles of the Declaration of Helsinki.
RESULTS
The mean age of the patients at the time of diagnosis was 11.3±4.7 years (range, 0.2-18.1 years). The mean SDS for height at the time of diagnosis was -4.2±1.5 and the mean SDS for BMI at the time of diagnosis was -0.2±1.2. Five (20%) of the cases had a family history of short stature and two (10%) had a history of parental consanguinity. Two cases had a history of difficult birth.Endocrinological evaluation of the patients, in whom ectopic neurohypophysis was detected on MRI, revealed that five (20%) cases had isolated GHD and 15 (80%) had MPHD. GHD was followed by TSH deficiency (13/20; 65%), FSH-LH deficiency (9/20; 45%) and ACTH deficiency (4/20; 20%), in decreasing order.MRI scans revealed stalk formation in three cases. One of these cases had isolated GHD and two had MPHD. MPHD was determined in all of the 17 cases without stalk formation on MRI.Examination of the patients for renal anomalies revealed renal anomalies in three (15%) cases: unilateral renal agenesis in one case, renal hypoplasia in one case, and double collecting system and unilateral renal agenesis in one case. All of the cases with renal anomalies had also MPHD.Two patients had testicular hypoplasia, one case had chromosomal abnormality [46, XX/47, XX + mar (6) karyotype], and one case had Fanconi anemia. Table 1 shows the clinical characteristics, endocrinological deficiencies of the patients as well as the presence of renal and additional anomalies. None of the patients had a family history of renal anomalies.
Table 1
Clinical features, endocrinological deficiencies, renal and other additional anomalies of the patients
Authors: J D Wegenke; D T Uehling; J B Wear; E S Gordon; J G Bargman; J S Deacon; J P Herrmann; J M Opitz Journal: Clin Genet Date: 1975 May-Jun Impact factor: 4.438
Authors: P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington Journal: Hum Mol Genet Date: 2001-01-01 Impact factor: 6.150
Authors: K Machinis; J Pantel; I Netchine; J Léger; O J Camand; M L Sobrier; F Dastot-Le Moal; P Duquesnoy; M Abitbol; P Czernichow; S Amselem Journal: Am J Hum Genet Date: 2001-09-20 Impact factor: 11.025
Authors: Luciani R Carvalho; Kathryn S Woods; Berenice B Mendonca; Nathalie Marcal; Andrea L Zamparini; Stefano Stifani; Joshua M Brickman; Ivo J P Arnhold; Mehul T Dattani Journal: J Clin Invest Date: 2003-10 Impact factor: 14.808
Authors: Erich Roessler; Yang-Zhu Du; Jose L Mullor; Esther Casas; William P Allen; Gabriele Gillessen-Kaesbach; Elizabeth R Roeder; Jeffrey E Ming; Ariel Ruiz i Altaba; Maximilian Muenke Journal: Proc Natl Acad Sci U S A Date: 2003-10-27 Impact factor: 11.205
Authors: R Nishinakamura; Y Matsumoto; K Nakao; K Nakamura; A Sato; N G Copeland; D J Gilbert; N A Jenkins; S Scully; D L Lacey; M Katsuki; M Asashima; T Yokota Journal: Development Date: 2001-08 Impact factor: 6.868
Authors: Taryn Youngstein; Patrycja Hoffmann; Ahmet Gül; Thirusha Lane; Rene Williams; Dorota M Rowczenio; Huri Ozdogan; Serdal Ugurlu; John Ryan; Len Harty; Sean Riminton; Alex P Headley; Joachim Roesler; Norbert Blank; Jasmin B Kuemmerle-Deschner; Anna Simon; Adrian S Woolf; Philip N Hawkins; Helen J Lachmann Journal: Rheumatology (Oxford) Date: 2017-12-01 Impact factor: 7.580